In addition, our functional enrichment analysis identified metabolic signaling pathways associated with high-risk GBM, including WNT signaling pathway, MAPK signaling pathway, ERBB signaling pathway and pathways in cancer. This evidence concerns the gene EGFR and glioblastoma.